Authors : Dr. Murthysetty Likhitha; Ms. Seerla Surarchita; Dr. Sridhar Yeshamaina

Volume/Issue : Volume 9 - 2024, Issue 9 - September

Google Scholar : https://tinyurl.com/277zd6x8

Scribd : https://tinyurl.com/22mv5688

DOI : https://doi.org/10.38124/ijisrt/IJISRT24SEP1485

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Computerized disruption in the drug industry refers to a revolutionary shift in customary processes in drug discovery, assembly, and patient consideration, spurred by emerging technologies. The unification of artificial intelligence (AI) and machine learning (ML) accelerates the development of new drugs by analysing large datasets to identify potential rivals for existing medications and predict patient responses. Digital therapies (DTx) are evidence-based programming interventions that improve medication adherence and chronic illness management while providing accessible and personalized medical service arrangements. Cloud computing and enormous information examination smooth out information reconciliation and investigation, empowering more productive innovative work processes. These innovations support the improvement of customized medication by utilizing genomic and clinical information, cultivating the making of designated treatments. The Internet of Things (IoT) upgrades the drug production network by checking ecological circumstances and guaranteeing the respectability of medication conveyance, while blockchain innovation guarantees information trustworthiness and straightforwardness, especially in clinical preliminaries and production network the executives. Regulatory Technology (RegTech) computerizes consistence processes, decreasing expenses and guaranteeing adherence to administrative norms. Furthermore, additive manufacturing (3D printing) speeds up drug prototyping and the creation of customized measurements structures, while supportability drives driven by advanced development lessen the natural effect of drug tasks. As computerized advances keep on developing, they offer uncommon chances to further develop effectiveness, lessen expenses, and improve patient results in the drug area. The fruitful coordination of these advancements presents difficulties however vows to alter the business by making medical services more customized, productive, and available.

Keywords : Artificial Intelligence, Digital Therapeutics, The internet of things (IoT), RegulatoryTech (RegTech), 3D Printing.

References :

1. Sharma A, Harrington RA, McClellan MB. Digital health innovation: A payer perspective on promises and challenges. Health Aff (Millwood). 2018;37(2):233-241. doi:10.1377/hlthaff.2017.1113.
2. Topol EJ. High-performance medicine: The convergence of human and artificial intelligence. Nat Med. 2019;25(1):44-56. doi:10.1038/s41591-018-0300-7.
3. Iyengar S, Sweeney L, Monteith S. Clinical trials and the digital health landscape. Digit Med. 2020;3:40. doi:10.1038/s41746-020-0237-0.
4. Wang L, Alexander CA. Big data in medical applications and health care. J Comput Sci Syst Biol. 2020;13(2):41-50. doi:10.4172/jcsb.1000310.
5. Hughes B, Hughes A, Wareham J. Digital transformation of the pharmaceutical industry: Opportunities and challenges. Deloitte Insights. 2021. Available from: https://www2.deloitte.com/insights/us/en/industry/life-sciences/digital-transformation-pharma.html.
6. Karimi M, Fakhri A, Shamsaei N, Ahmadi H. The impact of blockchain technology on the pharmaceutical supply chain: A case study. J Pharm Sci Innov. 2021;10(3):133-145. doi:10.7897/2277-4572.100329.
7. Agrawal, P. (2016). Digital Solutions in Pharmaceuticals and Healthcare by MedHawker. Retrieved from       http://www.slideshare. net/PankajAgrawal45/digital-solutions-in-pharmaceuticals-andhealthcare-by-medhawker.
8. Sultana, A., Maseera, R., Rahamanulla, A. et al. Emerging of artificial intelligence and technology in pharmaceuticals: review. Futur J Pharm Sci 9, 65 (2023). https://doi.org/10.1186/s43094-023-00517-w
9. Ahuja AS (2019) The impact of artifcial intelligence in medicine on the future role of the physician. PeerJ 7:e7702
10. Colombo S (2020) Applications of artifcial intelligence in drug delivery and pharmaceutical development. In: Artifcial intelligence in healthcare, pp 85–116.